(Q43118132)

14 November 2017

title

Polymorphisms in CYP11B2 and CYP11B1 genes associated with primary hyperaldosteronism (English)

1 reference

14 November 2017

Guo-xi Zhang

1

1 reference

14 November 2017

Bao-jun Wang

2

1 reference

14 November 2017

Jin-zhi Ouyang

3

1 reference

14 November 2017

Xi-yuan Deng

4

1 reference

14 November 2017

Xin Ma

5

1 reference

14 November 2017

Hong-zhao Li

6

1 reference

14 November 2017

Zhun Wu

7

1 reference

14 November 2017

Shuang-lin Liu

8

1 reference

14 November 2017

Hua Xu

9

1 reference

14 November 2017

Xu Zhang

10

1 reference

14 November 2017

publication date

26 March 2010

1 reference

14 November 2017

published in

Hypertension Research

1 reference

14 November 2017

volume

33

1 reference

14 November 2017

issue

5

1 reference

14 November 2017

page(s)

478-484

1 reference

Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.21

Role of steroid 11 beta-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.21

The Product of the CYP11B2 Gene Is Required for Aldosterone Biosynthesis in the Human Adrenal Cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.21

Juvenile hypertension, the role of genetically altered steroid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.21

Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone-to-renin ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.21

A biallelic gene polymorphism of CYP11B2 predicts increased aldosterone to renin ratio in selected hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.21

Polymorphic variation in the 11beta-hydroxylase gene associates with reduced 11-hydroxylase efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.21

Association between Aldosterone Production and Variation in the 11β-Hydroxylase (CYP11B1) Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.21

Polymorphic differences from normal in the aldosterone synthase gene (CYP11B2) in patients with primary hyperaldosteronism and adrenal tumour (Conn's syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.21

Association of Lys173Arg polymorphism with CYP11B2 expression in normal adrenal glands and aldosterone-producing adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.21

Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.21

CYP11B2-CYP11B1 haplotypes associated with decreased 11 beta-hydroxylase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.21

Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.21

Genetic variation at the locus encompassing 11-beta hydroxylase and aldosterone synthase accounts for heritability in cortisol precursor (11-deoxycortisol) urinary metabolite excretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.21

Effect of variation in CYP11B1 and CYP11B2 on corticosteroid phenotype and hypothalamic-pituitary-adrenal axis activity in hypertensive and normotensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.21

Aldosterone synthase gene variation and adrenocortical response to sodium status, angiotensin II and ACTH in normal male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.21

Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese: the Suita Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.21

Genetic determination of plasma aldosterone levels in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.21

Haplotype analysis of aldosterone synthase gene (CYP11B2) polymorphisms shows association with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.21

Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.21

7 January 2021

CYP11B2 gene polymorphisms in idiopathic hyperaldosteronism

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.21

7 January 2021

Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.21

7 January 2021

Further evaluation of saline infusion for the diagnosis of primary aldosteronism

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.21

7 January 2021

Haplotype analysis of CYP11B2

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.21

7 January 2021

Aldosterone synthase gene T-344C polymorphism, sodium and blood pressure in a free-living population: a community-based study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.21

7 January 2021

Identifiers

DOI

10.1038/HR.2010.21

1 reference

14 November 2017

1 reference